How could the second Trump administration affect the federal 340B Drug Pricing Program? It’s yet to be determined, according to policy experts.
Predicting how the election could ultimately affect the program “is above my pay grade,” joked Maureen Testoni, JD, the president and CEO of 340B Health, a nonprofit organization representing more than 1,500 hospitals and health systems that participate in the 340B program. However, during President-elect Donald